VintaBio Services
VintaBio Services

We offer a full array of key services in our
cutting-edge facility, guiding you from initial
discovery through to final delivery.

Services

Each day we work to advance innovative manufacturing
technologies that promise cures, making cell and gene
therapies more accessible to everyone.

Process Development

We offer an end-to-end solution for viral vector manufacturing, from cell line to drug product, emphasizing process robustness and quality. Our platform approach minimizes new development, allowing for the rapid creation of toxicology batches shortly after contract signing. With Quality by Design (QbD) principles, we transition directly to GMP production, saving you time and resources for study design.

  • Platform Bridging
  • Pre-clinical Material Production
  • Toxicology Material Production
  • Scale up & Out
  • Process Characterization
  • QbD & CMC Support
  • Analytical Development and Tox Release
  • Formulation Development

cGMP Manufacturing

Our commitment to quick clinic delivery and accurate execution is fundamental to our approach. With an integrated supply chain and standardized documentation strategies, we significantly reduce GMP readiness timelines and maintain a sharp focus on the CMC specifics of your program.

  • cGMP Cell Line
  • AAV Production
  • LVV Production
  • Process Validation
  • CMC Support
  • cGMP Analytical Testing
  • Stability Strategy Support
  • Assay Qualification & Validation
  • Formulation and Fill/Finish

Analytical Development

Our analytical services are focused on viral vector product release, emphasizing biological assays crucial for quality approval. Our team is equipped to handle everything from assay transfer to qualification and validation, aiming to effectively bring your ideas to life.

  • Assay Development
  • Assay Qualification & Validation
  • In Process Sample Testing
  • Lot Release Testing
  • Stability Support
VintaBio Explore Facility
VintaBio Explore Facility

Explore the facility

Our advanced facility is meticulously designed to meet cGMP standards and tailored for the efficient and scalable production of viral vectors.

Facility details

22,434 sq ft

BSL2- ISO7/ISO8

5 dedicated, cGMP suites

  • Cell expansion
  • Solution Prep
  • Processing (2)
  • Fill/Finish

Dedicated Process Development
& Toxicology (GLP)

Dedicated RUO Vector Core

On-site Warehouse
& Cold-Chain Storage

24/7 environmental monitoring of
production suites and cold storage

Integrated Analytical Suite

  • Cell based assays, compendial assays
  • Bioburden
  • dPCR, ELISA
VintaBio Facilities Map
  • Research Vector Core & PD Toxicology
  • cGMP Suites
  • Fill /Finish
  • QC Testing Suite
  • Office

Quality is at the core of what we do

Our comprehensive quality assurance program means that
viral vector products are manufactured and tested in full
compliance with cGMP regulations and adhere to FDA Good
Manufacturing Practice (GMP) requirements.

With more than 40 years of quality assurance program
management, our team has adopted a “right first time”
culture, dedicated to proactive quality program
management to ensure the quality of your product.